There has been a marked decrease in the incidence of cervical cancer thanks to cytological screening with the Pap smear test. In Belgium, this screening is rather opportunistic. Over 39% of Belgian women between 25 and 64 years of age are never or only rarely screened by cytological tests. Moreover, there is an excess use of Pap smears because of women who rely on their yearly cervical smear and because many Pap smears are obtained from women beyond the target age range of 25 to 64 years. Sexually active adolescents are increasingly being recognized as a population distinct from adult women. They are at a high risk of acquiring the human papillomavirus (HPV), but most infections and cervical intraepithelial lesions caused by HPV are efficiently cleared by the immune system. We present a description of cervical cancer screening in Belgium using the database of the National Health Insurance Institute (RIZIV/INAMI) and the Belgian Health Care Knowledge Centre (KCE). We describe why elimination of Pap testing in the adolescent population reduces costs and harms without increasing cervical cancer rates. Expectant management, education on the risk factors for cervical cancer and HPV persistence, and HPV vaccination are very important in adolescents and young adults.
Introduction
Cervical cancer is the third most common cancer in women worldwide and knowledge of its cause and pathogenesis has been expanding rapidly (Ferlay et al., 2010) .
During the last several decades, there has been a marked decrease in the incidence of cervical cancer. This has been attributed to cytological screening with the Pap smear test, which allows for the detection of precancerous lesions as well as the detection of cancerous lesions at an earlier stage. Cervical cancer screening programs are an effective prevention measure when they can be fully implemented by healthcare systems and used by almost all women (Widdice and Moscicki, 2008) . In Belgium, cervical cancer screening is rather opportunistic, which means that Pap smears are obtained at the spontaneous initiative of the women. Over 39% of Belgian women between 25 and 64 years of age are never or only rarely screened for cervical cancer by cytological tests; however, many women rely on a yearly cervical smear (Arbyn et al., 2014) . In 2006, the Belgian Health Care Knowledge Centre (KCE) reported that about 400 000 Pap tests are performed on top of the 3-yearly screening (Hulstaert et al., 2006) .
Belgium is divided into three geographically separated regions: the Flemish region (female population 3.0 million), the Walloon region (1.7 million women), and the capital region of Brussels (0.5 million women). The organization of preventive healthcare in Belgium is, since the state reform in 1980, confined to the communities, whereas the relevant medical activities are being covered by the national health insurance. A formal cervical cancer-screening program, on the basis of the European guidelines, currently exists only in the Flemish community (Flanders).
The coverage of the target population (3-year Pap screening for women between 25 and 64 years of age) is only 61%. In the Walloon region, there is a slightly higher coverage compared with the Flemish region (63 vs. 60%), which is remarkable, given the fact that in the latter region, a screening campaign has been organized since the mid-1990s (Arbyn et al., 2014) .
In Belgium, 601 new cases of cervical cancer (world agestandardized rate 7.6/100 000 women-years) were reported by the Belgian Cancer Registry for the year 2010. Annual deaths estimated most recently in Belgium were 275 women for the year 2008 (Arbyn et al., 2011) .
It is now well established that almost 100% of invasive cervical cancers are caused by persistent infection with specific oncogenic or high-risk human papillomavirus (HPV) genotypes. Infection of the cervix with one or more high-risk types of HPV is a necessary but insufficient condition for the later development of cervical cancer (Schiffman et al., 2007) . HPV infection is usually transient and half of new HPV infections are undetectable within ∼ 6-12 months (Rodriguez et al., 2008) .
Infections that persist beyond 2 years do have a greater likelihood of progression to precancerous cervical lesions, with the risk of eventual progression to invasive cervical cancer. Still, when a carcinogenic HPV type is detected by HPV testing, a concurrent cytological abnormality is present about one-quarter to one-third of the time. Most of these abnormalities are equivocal or, at most, minor (Kovacic et al., 2006) .
With respect to cervical cancer prevention efforts, sexually active adolescent women are increasingly being recognized as a population distinct from adult women. The prevalence rates of transient HPV and abnormal Pap smear results in this population are high. Both low-grade and high-grade lesions caused by HPV can regress in adolescent and young adult women and an understanding of HPV virology, epidemiology, and the natural history of HPV and cervical cancer precursors in adolescents compared with adults is very important. The adverse psychological effects of these positive HPV tests can be high and the treatment of these cancer precursors is not without risks (Widdice and Moscicki, 2008) . Overscreening leads to unnecessary follow-up examinations (repeat Pap smears, colposcopies, biopsies) and procedures that are not required (conizations, laser treatment, cryotherapy). When we consider the risk of preterm birth, which is 1.5 times higher after conization, it is possible that more harm than good may be caused with these activities (Kyrgiou et al., 2006; Arbyn et al., 2008) . It is therefore important to focus on alternatives such as HPV vaccination, enforcing the 3-yearly intervals of screening by new reimbursement rules and HPV screening. Sexual health education for adolescents and providing information for healthcare workers can help optimize the screening.
Methodology
For the description of cervical cancer screening in Belgium, we used the database of the National Health Insurance Institute (RIZIV/INAMI) and the Belgian Cancer Registry between 2006 and 2013. The RIZIV/INAMI has a database of every reimbursable procedure or examination. Since 2006, data on Pap smears, biopsies, colposcopies, and conizations have been stored by age. The reimbursement of the multidisciplinary oncological care programs since 2003 and the creation of the specific law on the Cancer Registry in 2006 provided a firm legal basis for cancer registration in Belgium. This legislation makes cancer registration compulsory for the oncological care programs and the pathological anatomy laboratories. The law authorizes the Belgian Cancer Registry with the use of the national social security number (INSZ/NISS) as the unique identifier of the patient. Hospitals have to register all new cancer diagnoses, irrespective of whether the diagnosis was discussed during a multidisciplinary oncological consultation. Each tumor has to be recorded using a standard form including a defined set of variables. To code tumor characteristics, this dataset used the International Classification of Diseases for Oncology (ICD-O). The staging of the tumor has to be defined according to the TNM Classification of Malignant Tumours. In this article, we used direct information from these databases and carried out calculations such as percentages and crude-rate (new cases per 100 000/year). No complex statistical methodology was applied.
Results
In 2009, the reimbursement conditions in Belgium changed and reduced the total number of cervical cytology examinations. For example, 68 370 Pap smears were performed in women younger than 25 years of age in 2012 compared with 120 565 smears in 2008 (Table 1) . Since 2013, the reimbursement of screening cytology has changed again and now the 3-yearly Pap smear is completely free of charge. Table 2 , almost 123 000 Pap smears were obtained from women beyond the target age range of 25 to 64 years in 2012. Between 2006 and 2012, screening beyond the target age range led to 18% of all smears: 10% from women younger than 25 years old and almost 8% from women 65 years of age or older (Table 3 ).
As shown in
In 2012, more than 8000 conizations were performed in Belgium. More importantly, 4758 conizations were performed in women younger than 40 years of age. Of these, 712 conizations were even performed in women younger than 25 years of age. Table 4 shows the number of all cervical procedures performed among women younger than 25 years of age. A high incidence of colposcopy has been observed in this age group. The incidence of Pap smear/colposcopy has been on average 2.6. This means that for every two to three Pap smears, one colposcopic investigation is performed. The low biopsy rate in relation to colposcopy is quite surprising. It is possible that some colposcopies are not clinically indicated and used at the same time as a screening Pap smear because colposcopy is easily available.
In Table 1 , the incidence of cervical cancer by age in Belgium is shown. Between 2004 and 2011, 26 women between 20 and 24 years of age were diagnosed with an invasive cervical cancer. For the same period, cervical cancer was found in only three girls younger than 20 years of age.
For the year 2011, we categorized the new diagnoses also by stage on the basis of the seventh edition of the TNM classification (Table 5 ). To determine the stage, both clinical information and pathological results were used. Among women younger than 30 years of age, 77.6% were diagnosed with cervical cancer stage I. Two-thirds of patients (8/12) younger than 25 years old who were diagnosed with invasive cervical cancer were at stage IA. Only 3/12 (25%) had locally advanced disease (stage II). Disease stage was not known in one patient.
In Table 6 , we present an overview of newly diagnosed carcinoma in situ per age for the period between 2004 and 2011 in Belgium. Figure 1 shows that although premalignant lesions peak at the age of 35 years, the peak incidence for invasive cancer is between 40 and 50 years.
Discussion
Opportunistic screening activity is still predominant in many European countries including Belgium. Cervical cancer screening has often been offered in the context of anticonception so that the target group is younger women. In the Flemish region of Belgium, a screening campaign has been organized since the mid-1990s. Still, the current screening coverage in Belgium is only 61% in women 25 to 64 years of age. Arbyn et al. (2014) showed recently that between 2002 and 2006, the invitations were only sent to the target population in two of the five provinces of Flanders (Arbyn et al., 2014) . Moreover, no obvious impact of sending invitations to women was observed and excess use of Pap tests hardly changed over time. The median screening interval was 13 months. The excess use of cervical cytological examinations was 88%, which means that each screened woman received on average 1.88 smears over a time span of 3 years. Excess smear use was less high in the Flemish region (84%), highest in the Capital region (95%), and intermediate in the Walloon region (92%) (Arbyn et al., 2014) . 
Screening women younger than 25 years of age for cervical cancer can lead to adverse effects, which is unfortunate because the majority of abnormal lesions found in this age group will regress spontaneously without intervention. The numbers of all cervical cancer screenings performed in Belgium in women younger than 25 years of age over the last 6 years are quite high and have a huge impact on the public health budget, without clear benefits in terms of reduction of incidence or mortality compared with the screening recommended in European guidelines.
As shown in Table 2 , more than 38 000 women younger than 25 years of age underwent a Pap smear in 2012. Of these, more than 15 000 (40%) were even younger than 20 years of age. Moreover, and as shown in Table 4 , one colposcopy was performed for fewer than three Pap smears in women younger than 25 years of age in 2012.
The results of 712 conizations in women younger than 25 years of age may be marked in terms of the risk of preterm birth. In addition, there is a clear trend toward pregnancy and childbirth at an advancing age. Between 2010 and 2013, the fertility rate of women between 20 and 29 years of age decreased, whereas an increase was observed for woman older than 35 years of age. The mean age of Belgian women who give birth to their first child is 28.4 years as was reported recently by the Flemish agency 'Child and Family' (Van Bavel and De Hauw, 2014).
Among adolescents, cervical cancer is relatively rare and screening can lead to high costs and adverse events associated with overtreatment (Castle et al., 2011; Benard et al., 2012) . Spiryda et al. (2014) reported in a review that it is safe to delay HPV and Papanicolaou testing until the age of 21 years. In their 9-year review of Pap test data, they observed no increase in cervical cancer rates by delaying screening in the adolescent population and reported data consistent with the SEER data (Centers for disease control and Surveillance, Epidemiology and End Results). According to the SEER data, there is a 0.2% rate or ∼ 14 cancers a year in the 14-to 19-year-old group. This rate has not varied from year to year since the 1970s despite the previous practice of annual screening (Chan et al., 2003; Watson et al., 2008; Noone et al., 2012; Spiryda et al., 2014) . Cell types found in studies in these girls have been adenocarcinomas, endometrioïd, and clear cell carcinomas. These cell types are less likely to be detected on cervical cytology screening programs. Also, there are no precancerous lesions known for these types of cancers (Liebrich et al., 2009; Spiryda et al., 2014) . This is in agreement with our findings. The relationship between age and incidence of cervical cancer in Belgium is shown in Fig. 1 . Although premalignant lesions peak at the age of 35 years, the peak incidence for invasive cancer has been between 40 and 50 years. The data of this diagram are presented in Table 7 .
As shown in Table 1 , only 24 women in the age range between 20 and 24 years were diagnosed with invasive cervical cancer in Belgium in the period from 2004 until 2011. For the same period, cervical cancer was found in three girls younger than 20 years of age.
In Table 5 , the numbers of newly diagnosed cervical cancers for the year 2011 according to age and histology are presented. In the age group younger than 15 years, there was only one girl and she was diagnosed with a sarcoma. In the group of females between 15 and 20 years, two carcinomas were diagnosed. One case was microinvasive (Ia) and no information is available on the FIGO stage of the second case.
Well-organized screening programs have a greater impact than opportunistic screening because they have the potential to lead to greater participation of the target population at regular intervals, equity of access, and high likelihood of reaching women at higher risk. Moreover, organized screening implies the implementation of quality assurance measures, which should be monitored at each stage of the screening process. Implementation of a national program requires that there is a national policy that defines the screening age and interval and what method of screening will be used, as well as sufficient political and financial investment (Linos and Riza, 2000; Arbyn et al., 2009; Salo et al., 2014) . 
Invasive Ca Ca in situ
In the Netherlands, our northern neighbours, a nationwide screening program was started in 1989 for women aged 35-54 years with screening at 3-year intervals. Evaluation showed suboptimal performance and, in 1996, the program was restructured in terms of the management and financing of the program, organization, target age ranges (30-60 years), a longer screening interval (5 years), follow-up of abnormal results, and evaluation (Van Ballegooijen and Hermens, 2000) . The coverage increased markedly (currently around 80%) and there was an improvement in the follow-up compliance among screened women. Also, the side effects of screening were reduced by a decrease in the test positivity rate from over 10% to ∼ 2% (Rebolj et al., 2007 (Rebolj et al., , 2008 . Despite the longer screening interval and the lower percentage of women under follow-up, no increased incidence of interval cancer was noted and the incidence of cervical cancer was maintained at a very low rate (Rebolj et al., 2008; Van der Aa et al., 2008a , 2008b . This is in agreement with our results. Despite all the efforts made to obtain Pap smears, performing colposcopies and (unnecessary) treatments in women younger than 20 years of age, only two carcinomas were found. In 2011, 853 conizations were performed in females younger than 25 years of age and only 18 carcinomas were found in the pathologic results (Tables 4 and 5 ).
More important for preventive health screening for adolescents is sexual health education and strategies for behaviour risk reduction in the acquisition of sexually transmitted infections, such as HPV (Castellsagué et al., 2006) .
The prevalence of HPV appears to peak several years after sexual debut and several studies have indicated that sexually active young women have positive HPV test rates as high as 50% within 36 months of coitus (Brown et al., 2005) . Education and vaccination campaigns targeted at presexually active children and adolescents are therefore very important (Rodriguez et al., 2008; Chen et al., 2011) .
Regression of detectable HPV infection is common in adolescents with low-grade lesions. Greater than 90% of cytologically diagnosed low-grade squamous intraepithelial lesions (LSIL) and histologically diagnosed grade I cervical intraepithelial neoplasia revert to normal within 3 years. Sixty percent of cervical intraepithelial neoplasia II lesions in adolescents will regress within 3 years (Moscicki and Cox, 2010) .
Given that it is known that squamous intraepithelial lesion (SIL) is a result of HPV replication, it would be expected that the rates of SIL would parallel those of HPV, with the highest rates detected in adolescents. A higher rate of abnormal cytology in young women compared with older women was reported by Mount and Papillo (1999) , who reviewed 79 000 cytology slides. In the group of women aged 15-19 years, 3.9% had SIL compared with 1.3% in the group aged 30-39 years. The majority of adolescents were diagnosed with LSIL (2.5%), many fewer (0.7%) with high-grade squamous intraepithelial lesions (HSIL), and none of them had a carcinoma in situ (Mount and Papillo, 1999) . Recently, Ma et al. (2013) reported similar rates in a study of almost 57 000 adolescents. They found ASCUS or LSIL in 20% and HSIL in 0.5% of the Pap tests. There was only one adolescent with microinvasive cervical carcinoma, which was discovered during postadolescent follow-up Ma et al. (2013) . Moscicki (2005) reported that only 3% of the LSIL progresses to more advanced precancerous lesions in young women compared with 20 to 30% of older adult women (Moscicki et al., 2004; Moscicki, 2005) .
The development of HSIL requires persistent infection with high-risk HPV subtypes (Verhoeven et al., 2013) . Women with LSIL are required to undergo a repeat cytology after 6 months to decide whether they should be referred to a colposcopy unit or be referred back to the screening interval of 3 years. In this 6-month period of watchful waiting, information can be provided on how to improve systemic and local immunity to enhance the possibility of spontaneous clearance of HPV infection.
Smokers maintain an HPV infection significantly longer and have a lower probability of clearing an oncogenic infection compared with women who have never smoked (Giuliano et al., 2002; Castellsagué and Munoz, 2003; Smith et al., 2003; . Moreover, smoking duration was associated significantly with HPV clearance and a dose response was observed (Barton et al., 1988; Guarisi et al., 2009; Maucort-Boulch et al., 2010) . Verhoeven et al. (2013) proposed a daily consumption of probiotic during these 6 months. They showed a twice as high chance of clearance of cytological abnormalities (60 vs. 31%, P =0.05) in adolescents with HPV-positive LSIL diagnoses.
Following the introduction of HPV vaccination, a decreasing prevalence of HPV and incidence of HPVrelated disease has been reported. In Australia, for example, a near disappearance of genital warts in young women was found 4 years after implementation of the vaccination program (Brotherton et al., 2011; Read et al., 2011; Markowitz et al., 2013) . Prophylactic vaccines are expected to significantly reduce morbidity and mortality associated with HPV infections and will provide the greatest public health benefits if they are administered before initiation of sexual activity (Moscicki, 2005) . In 2010, HPV vaccination was added to the vaccination program in Flanders. Girls in the first year of secondary school (12 years of age) are the target group for vaccination. Data from the first 2 years of vaccination showed a participation rate of 85-90%, with vaccination coverage for full vaccination of 80-83%. HPV vaccination coverage in Flanders was high from the beginning of the vaccination program. Participation of school health services is of upmost importance to reach a high coverage at the start of a vaccination program in school-aged children (Simoens et al., 2009; Lefevere et al., 2011) . Since we initiated the vaccination program in 2010, an impact similar to that observed in Australia can be expected and, hopefully, this will lead to a decrease in the numbers of Pap smears, colposcopies, and conizations as shown in Table 4 .
Conclusion
The European Union currently recommends that cancer screening should only be offered in population-based organized programs with quality assurance at all levels. In Belgium, this organized, population-based screening program is lacking and 39% of the target population is currently not covered. Moreover, there is excess use of Pap smears because of women who rely on their yearly cervical smear and because many Pap smears are obtained from women beyond the target age range of 25 to 64 years. Unnecessary screening of adolescents in Belgium has its side effects on both health as well as economic scales.
Adolescent women are increasingly being recognized as a population distinct from adult women with respect to cervical cancer screening. Sexually active adolescents are at a high risk of acquiring HPV, but most infections are efficiently cleared by the immune system. Similarly, both low-grade and high-grade cervical intraepithelial lesions caused by HPV can regress in this young population.
Elimination of Pap testing in the adolescent population reduces the costs, anxiety, and morbidity of unnecessary surgical procedures. Education on the risk factors for cervical cancer and HPV persistence and achieving a high coverage for HPV vaccination are expected to reduce the burden of the disease. It is very important to make gynaecologists, general practitioners, and healthcare workers aware of the low screening coverage and high overscreening. They should focus on enforcing the 3-yearly intervals of cervical screening and on the 39% of women who are currently not screened. Moreover, new reimbursement rules for follow-up examinations such as colposcopy can improve the screening and force us to only use colposcopy according to the accepted guidelines.
